This website uses cookies to ensure that we give you the best experience on our website. Click here for more information.


Terms of Use

The information contained in this site is for healthcare professionals only.

I am not a healthcare professional I confirm to be a healthcare professional
treat with prolia®

Prolia® (denosumab): subcutaneous injection for osteoporosis

Prolia (denosumab) is administered as a subcutaneous injection of a fixed dose of 60mg once every 6 months. Administration should be performed by an individual who has been adequately trained in injection techniques.

Prolia® Product Specifics

Prolia® (denosumab) is a sterile, preservative-free solution containing the active ingredient denosumab. Prolia® (denosumab) is presented in a prefilled syringe at a strength of 60mg/ml. 

learn more

Prolia® Posology and Method of Administration

Prolia® (denosumab) is an injection for osteoporosis administered subcutaneously every six months.

learn more

Prolia® Side Effects & Safety Information

Learn which denosumab side effects to look out for and safety precautions to take in patients with osteoporosis on treatment with Prolia®

learn more